To examine the clinical significance of MEST dysregulation in esophageal cancer, we determined the expression of MEST in 40 ESCC tissues and paired normal tissues, and the qRT-PCR results showed the upregulation of MEST in the majority of ESCC cases (31/40 cases, 77.5%) (Fig. 2a). Here, MEST is linked to esophageal cancer.